Profil
David E.
Leahy was the founder of Molplex Ltd.
which was founded in 2010, where he held the title of Chief Executive Officer.
He also worked as a Principal at AstraZeneca PLC.
Prior to that, he was a Professor at The University of Newcastle from 2007 to 2010, where he held the title of Professor in 2010.
Anciens postes connus de David E. Leahy
| Sociétés | Poste | Fin |
|---|---|---|
| The University of Newcastle | Corporate Officer/Principal | 01/01/2010 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Molplex Ltd.
 Molplex Ltd. Pharmaceuticals: MajorHealth Technology Molplex Ltd. develops pharmaceutical drugs and ingredients. It focuses on medicines for cancer, infection, stratified medicine, autoimmune diseases and inflammation. Its Optiplex, a drug optimization platform estimates the outcomes of clinical trials integrated with laboratory operations for synthesis and screening. The company was founded in June 2010 and is headquartered in Macclesfield, the United Kingdom. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Molplex Ltd.
Molplex Ltd. Pharmaceuticals: MajorHealth Technology Molplex Ltd. develops pharmaceutical drugs and ingredients. It focuses on medicines for cancer, infection, stratified medicine, autoimmune diseases and inflammation. Its Optiplex, a drug optimization platform estimates the outcomes of clinical trials integrated with laboratory operations for synthesis and screening. The company was founded in June 2010 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
